在慢性鼻炎与鼻的depemokimab:一个转折点还是错过的机会?
Enrico Heffler1, Giovanni Paoletti1
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy; Personalized Medicine, Asthma and Allergy, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Med (New York, N.Y.)
|May 10, 2025
概括
德佩莫基巴布 (Depemokibab) 是一种抗联素-5抗体,在患有鼻多重症的慢性鼻炎时显示出安全性和有效性. 需要进一步的研究来确定其与其他生物疗法相比的临床益处.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 鼻多重症慢性鼻炎 (CRSwNP) 是一种使人虚弱的上呼吸道炎症疾病.
- 针对2型炎症的生物疗法,如抗干白素-5 (IL-5) 药物,越来越多地用于严重的CRSwNP.
- 德佩莫基巴布是一种长效的抗IL-5单克隆抗体,在CRSwNP中进行了评估.
研究的目的:
- 评估depemokibab在CRSwNP患者中的安全性和有效性.
- 为了比较depemokibab与安慰剂和其他生物疗法的临床益处.
主要方法:
- 在ANCHOR-1和ANCHOR-2随机,安慰剂对照试验中,评估了CRSwNP患者的depemokibab.
- 关键的疗效终点包括鼻息肉得分和症状严重程度.
- 此外,还评估了安全性和耐受性.
主要成果:
- 在ANCHOR试验中,depemokibab与安慰剂相比,在统计学上显示出有效性.
- 药物一般耐受性良好,显示可接受的安全性.
- 然而,与现有的生物治疗相比,临床益处似乎有限.
结论:
- 德佩莫基巴布是对CRSwNP的安全和统计有效的.
- 它的临床实用性可能受到相对于其他生物制剂的适度益处的限制.
- 优化患者选择和探索缩短剂量间隔需要进一步研究.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
29.8K
06:13Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
16.6K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
161
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
161
01:17Drugs Used in Lower Respiratory Disorders: Overview
247
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
247